MedPath

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Phase 4
Completed
Conditions
Long-Acting Injection
LAI
Aripiprazole
Schizophrenia
Antipsychotics
Interventions
Registration Number
NCT03376763
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Brief Summary

Interventional, multicenter, open-label, 20 weeks study

* To identify efficacy and safety in switching from oral aripiprazole to Abilify Maintena.

* To identify efficacy and safety in switching from oral atypical antipsychotics other than aripiprazole to Abilify Maintena

Detailed Description

We would like to evaluate the efficacy and safety when switching to Abilify Maintena according to the approved indication of Abilify Maintena, for subjects who are taking oral antipsychotic drugs. It is expected that this will serve as a basis for suggesting a successful switching guideline from oral antipsychotics to Abilify Maintena, which can be applicable in clinical practice.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1Abilify maintenaSchizophrenia patients who are taking oral aripiprazole will be switched to Abilify maintena
Group 2Abilify maintenaSchizophrenia patients who are taking other oral atypical antipsychotics will be switched to Abilify maintena
Primary Outcome Measures
NameTimeMethod
PANSS total score16 weeks

Change in PANSS total score from baseline to Week 16

Secondary Outcome Measures
NameTimeMethod
CGI-S16 weeks

Change in CGI-S (severity) from baseline to Week 16

IAQ score16 weeks

Mean IAQ score at Week 16

CGI-I16 weeks

Mean CGI-I (improvement) score at Week 16

PANSS positive and negative subscale score16 weeks

Change in PANSS positive and negative subscale score from baseline to Week 16

Trial Locations

Locations (27)

Cha Bundang Medical Center

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Eulji University Hospital

🇰🇷

Daejeon, Korea, Republic of

Kangbuk Samsung Hospital

🇰🇷

Seoul, Korea, Republic of

Konkuk University Chungju Hospital

🇰🇷

Chungju, Chungcheongbuk-do, Korea, Republic of

Gongju National Hospital

🇰🇷

Gongju, Chungcheongnam-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si,, Gyeonggi-do, Korea, Republic of

Hanyang University Guri Hospital

🇰🇷

Guri-si, Gyeonggi-do, Korea, Republic of

Yong-In Mental Hospital

🇰🇷

Yongin-si, Gyeonggi-do, Korea, Republic of

The Catholic University of Korea Uijeongbu ST. Mary'S Hospital

🇰🇷

Uijeongbu Si, Gyeonggi-do, Korea, Republic of

Jeju National University Hospital

🇰🇷

Jeju, Jeju-do, Korea, Republic of

Chonbuk National University Hospital

🇰🇷

Jeonju, Jeollabuk-do, Korea, Republic of

Kyungpook National University Hospital

🇰🇷

Daegu, Korea, Republic of

Chungnam National University Hospital

🇰🇷

Daejeon, Korea, Republic of

Konyang University Hospital

🇰🇷

Daejeon, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

International St. Mary's Hospital

🇰🇷

Incheon, Korea, Republic of

Inje University Haeundae Paik Hospital

🇰🇷

Pusan, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Ewha Womans University Mokdong Hospital

🇰🇷

Seoul, Korea, Republic of

Eulji General Hospital

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Hospital

🇰🇷

Seoul, Korea, Republic of

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hosipital

🇰🇷

Seoul, Korea, Republic of

Yeungnam University Medical Center

🇰🇷

Daegu, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Pusan National University Yangsan Hospital

🇰🇷

Pusan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath